Alyeska Investment Group, L.P. - 30 Jun 2025 SCHEDULE 13G Report for Immunic, Inc. Common Stock, $0.0001 par value (IMUX)

Filing Manager
Alyeska Investment Group, L.P.
Reporting Manager
Alyeska Investment Group, L.P.
Security
Immunic, Inc. Common Stock, $0.0001 par value
Symbol
IMUX
Shares outstanding
95,817,535 shares
Disclosed Ownership
9,485,936 shares
Ownership
9.9%
Form type
SCHEDULE 13G
Filing time
14 Aug 2025, 17:38:14 UTC
Date of event
30 Jun 2025
Next filing
14 Nov 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Alyeska Investment Group, L.P. 9.9% 9,485,936 0 9,485,936 Jason Bragg Jason Bragg | Chief Financial Officer
Alyeska Fund GP, LLC 9.9% 9,485,936 0 9,485,936 Jason Bragg Jason Bragg | Chief Financial Officer
Anand Parekh 9.9% 9,485,936 0 9,485,936 Anand Parekh Anand Parekh | Self